Highmark Health revenue grows 9% year over year to $29.4 billion; reports $50 million net income through year-end 2024 despite industry challenges

  • Highmark health plans report negative operating performance while solving medical trend costs across the industry

  • Alegeni Health Network Report increases revenue 9 % and improves operating performance year by year

PittsburgFor, for, for,. March 13, 2025 / PR NewsVire/-High Mark Health announces stable financial results for the entire year, 2024, reporting .4 29.4 billion In the tax, million 50 million In net income, and 9 209 million In operating losses.

These results reflect the negative operating performance of highmark health projects, which faced pressure from industrialized medical trends, which continued for the fourth quarter of 2024. United Connodia Dental and HM Insurance Group saw permanent operating performance, which increased dental membership and pricing discipline. Highmark Health Provider Network, Alegeni Health Network (AHN) also saw operating improvement by increasing the amount of patients in all areas of maintenance. High Mark Health maintained a strong balance sheet 7 11.7 billion In cash and investment and net assets 8 9.8 billion As if December 31, 2024.

“Our industry needs a more economically sustainable approach that provides better health experiences and results. This is exactly what we have taken with our long -term change strategy and living health model.” David HolbergPresident and Chief Executive Officer of High Mark Health. “The latest version of our living health model is in Western Pennsylvania. In 2024, Hymark and Ahn launched a value -based program in which they shared their common population management goals and financial risks. It uniquely builds more than a decade of coordinating pay -based pay -based pay -based pay -based paying payments, which have improved consumer satisfaction and health results by controlling the overall costs for members and group consumers of the health project. “

“Although our stable income has improved, we face the industry’s main heads and medical cost trends, including prescription drugs, especially GLP-4, the effects of medical refining, and high use across the country, especially for medical advantage portfolio.” Carl DailyChief Financial Officer and Treasurer of High Mark Health. “We expect this industrial challenge to continue, but our comprehensive strategy and strong financial position will allow us to go to these difficulties while financing our change strategy and provides strength. We are ready for this difficult environment and ready to develop it better.”

Leave a Comment